CZI's philosophy is to pursue transformative, paradigm-shifting medical advances. The organization explicitly avoids incremental improvements, such as extending a cancer patient's life by a few months. Instead, it directs all its resources towards ambitious goals like outright curing or preventing diseases, fostering a culture of "unbridled ambition."

To vet ambitious ideas like self-sailing cargo ships, first ask if they are an inevitable part of the world in 100 years. This filters for true long-term value. If the answer is yes, the next strategic challenge is to compress that timeline and build it within a 10-year venture cycle.

CZI's audacious goal wasn't literal, but a forcing function. When scientists called it impossible, CZI asked "Why?" This revealed the core bottleneck wasn't a lack of therapies, but a lack of shared tools and data. This insight redirected their entire strategy from funding individual grants to building foundational infrastructure for the entire scientific community.

CZI focuses on creating new tools for science, a 10-15 year process that's often underfunded. Instead of just giving grants, they build and operate their own institutes, physically co-locating scientists and engineers to accelerate breakthroughs in areas traditional funding misses.

CZI set an audacious goal to cure all disease. When scientists deemed it impossible, CZI's follow-up question, "Why not?" revealed the true bottleneck wasn't funding individual projects, but a systemic lack of shared tools, which then became their core focus.

CZI targets a 10-15 year time horizon for its major scientific initiatives. This is a strategic sweet spot, similar to a venture-backed company's lifecycle, which is long enough for ambitious goals but concrete enough for a team to see a project through.

CZI identified a market failure in scientific funding. Government grants favor short-term, small-scale investigations. CZI fills this gap by building long-term, expensive, foundational tools (like imaging and virtual cell models) that accelerate the entire field, rather than just funding the "next best grant."

Instead of funding small, incremental research grants, CZI's philanthropic strategy focuses on developing expensive, long-term tools like AI models and imaging platforms. This provides leverage to the entire scientific community, accelerating the pace of the whole field.

CZI's goal to cure all diseases by 2100 is seen as unambitious by AI experts but overly ambitious by biologists. This difference in perspective forces biologists to define barriers and AI researchers to understand data complexities, fostering a more credible, grounded approach to innovation.